Spremljaj
Nikhil Kateja
Nikhil Kateja
Department of Chemical Engineering, IIT Delhi
Preverjeni e-poštni naslov na iitd.ac.in
Naslov
Navedeno
Navedeno
Leto
Recent developments in chromatographic purification of biopharmaceuticals
AS Rathore, D Kumar, N Kateja
Biotechnology letters 40, 895-905, 2018
1012018
Continuous precipitation of process related impurities from clarified cell culture supernatant using a novel coiled flow inversion reactor (CFIR)
N Kateja, H Agarwal, A Saraswat, M Bhat, AS Rathore
Biotechnology journal 11 (10), 1320-1331, 2016
642016
Use of HPLC as an enabler of process analytical technology in process chromatography
A Tiwari, N Kateja, S Chanana, AS Rathore
Analytical chemistry 90 (13), 7824-7829, 2018
582018
Non-protein A purification platform for continuous processing of monoclonal antibody therapeutics
N Kateja, D Kumar, S Sethi, AS Rathore
Journal of Chromatography A 1579, 60-72, 2018
482018
Process integration and control in continuous bioprocessing
AS Rathore, N Kateja, D Kumar
Current opinion in chemical engineering 22, 18-25, 2018
462018
Economic assessment of continuous processing for manufacturing of biotherapeutics
P Gupta, N Kateja, S Mishra, H Kaur, AS Rathore
Biotechnology Progress 37 (2), e3108, 2021
452021
Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study
N Kateja, H Agarwal, V Hebbi, AS Rathore
Biotechnology progress 33 (4), 998-1009, 2017
392017
Integrated chromatographic platform for simultaneous separation of charge variants and aggregates from monoclonal antibody therapeutic products
N Kateja, D Kumar, A Godara, V Kumar, AS Rathore
Biotechnology Journal 12 (11), 1700133, 2017
372017
Role of raw materials in biopharmaceutical manufacturing: risk analysis and fingerprinting
AS Rathore, D Kumar, N Kateja
Current opinion in biotechnology 53, 99-105, 2018
332018
Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
AS Rathore, G Thakur, N Kateja
Biotechnology and Bioengineering 120 (2), 333-351, 2023
262023
Contribution of protein A step towards cost of goods for continuous production of monoclonal antibody therapeutics
V Bansode, P Gupta, N Kateja, AS Rathore
Journal of Chemical Technology & Biotechnology 97 (9), 2420-2433, 2022
242022
A novel reactor configuration for continuous virus inactivation
N Kateja, N Nitika, RS Fadnis, AS Rathore
Biochemical Engineering Journal 167, 107885, 2021
182021
Complete or periodic continuity in continuous manufacturing platforms for production of monoclonal antibodies?
N Kateja, A Tiwari, G Thakur, AS Rathore
Biotechnology Journal 16 (7), 2000524, 2021
172021
Continuous downstream processing for production of biotech therapeutics
AS Rathore, N Kateja, H Agarwal
Continuous Biomanufacturing‐Innovative Technologies and Methods: Innovative …, 2017
172017
Development of an integrated continuous PEGylation and purification process for granulocyte colony stimulating factor
N Kateja, S Dureja, AS Rathore
Journal of Biotechnology 322, 79-89, 2020
162020
Continuous processing for the production of biopharmaceuticals
H Agarwal, AK Sharma, N Kateja, A Rathore
MJH Life Sciences 29, 14–19-14–19, 2016
102016
Optimization of the in-vitro refolding of biotherapeutic Fab Ranibizumab
R Sharma, A Anupa, N Kateja, AS Rathore
Biochemical Engineering Journal 187, 108601, 2022
82022
A Coiled Flow Inversion Reactor Enables Continuous Processing
AS Rathore, N Kateja
BioPharm International 29 (12), 32–35, 2016
52016
A coiled flow inverter reactor for continuous refolding of denatured recombinant proteins and other mixing operations
AS Rathore, KDP Nigam, M Pathak, H Agarwal, AK Sharma, N Kateja, ...
Patent WO 2016116947, A1, 2016
52016
A novel method for continuous chromatographic separation of monoclonal antibody charge variants by combining displacement mode chromatography and step elution
A Anupa, V Bansode, N Kateja, AS Rathore
Biotechnology Progress 40 (1), e3395, 2024
12024
Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.
Članki 1–20